Vico Therapeutics
PrivateLast Round
Series B
Extension
Jun 24, 2024
Total Funding Raised
$114.1M
Company Overview
Vico Therapeutics is a biotechnology company that develops RNA-modulating antisense oligonucleotide (ASO) therapies aimed at treating patients with severe, rare neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vico Therapeutics Comparables
Compare Vico Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wave Life Sciences | 81% | |
| ProQR Therapeutics | 79% | |
| Stoke Therapeutics, Inc. | 76% | |
Vico Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 24, 2024 | ||||
| Series B | Jan 5, 2024 | ||||
| Series A | Jul 29, 2020 |
Vico Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Series B Extension, Series B |
| EQT Life Sciences | Series B Extension, Series A, Series B |
| Idinvest Partners | Series A |
| Seroba Life Sciences | Series B Extension |
| Pontifax Credit | Series A |
| Droia Ventures | Series B Extension, Series A, Series B |
| Pureos Bioventures | Series A, Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Product candidate VO659 is undergoing a first-in-human study for rare neurological disorders.
- Jun 22, 2025
Job posting indicates preparation for IPO as part of growth strategy.
Vico Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vico Therapeutics's valuation, stock price, and market status.